These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36374357)

  • 1. Psychedelic-Assisted Therapy for People with Eating Disorders.
    Gukasyan N; Schreyer CC; Griffiths RR; Guarda AS
    Curr Psychiatry Rep; 2022 Dec; 24(12):767-775. PubMed ID: 36374357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.
    Calder A; Mock S; Friedli N; Pasi P; Hasler G
    Eur Neuropsychopharmacol; 2023 Oct; 75():1-14. PubMed ID: 37352816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.
    Harding F; Seynaeve M; Keeler J; Himmerich H; Treasure J; Kan C
    J Integr Neurosci; 2021 Sep; 20(3):551-560. PubMed ID: 34645088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.
    Otterman LS
    J Bioeth Inq; 2023 Mar; 20(1):31-39. PubMed ID: 36534233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.
    Spriggs MJ; Kettner H; Carhart-Harris RL
    Eat Weight Disord; 2021 May; 26(4):1265-1270. PubMed ID: 32895801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.
    VanderZwaag B; Garcia-Romeu A; Garcia-Barrera MA
    Ther Adv Psychopharmacol; 2024; 14():20451253241264812. PubMed ID: 39132012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder.
    Ledwos N; Rodas JD; Husain MI; Feusner JD; Castle DJ
    J Psychopharmacol; 2023 Jan; 37(1):3-13. PubMed ID: 36515406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.
    Downey AE; Boyd M; Chaphekar AV; Woolley J; Raymond-Flesch M
    Int J Eat Disord; 2023 Nov; 56(11):2142-2148. PubMed ID: 37551650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review.
    Cuerva K; Spirou D; Cuerva A; Delaquis C; Raman J
    Eur Eat Disord Rev; 2024 Sep; 32(5):980-1001. PubMed ID: 38783636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.
    Meir P; Taylor L; Soares JC; Meyer TD
    J Affect Disord; 2023 Feb; 323():748-754. PubMed ID: 36535547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.
    Wolfgang AS; Hoge CW
    Curr Psychiatry Rep; 2023 Oct; 25(10):513-532. PubMed ID: 37682446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the numbers: reimagining healing with psychedelics for eating disorders.
    Lafrance A; Spriggs MJ; Gukasyan N; Peck SK
    J Eat Disord; 2024 Sep; 12(1):148. PubMed ID: 39350242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic-assisted therapy for people with gambling disorder?
    Romero P; Czakó A; van den Brink W; Demetrovics Z
    J Behav Addict; 2024 Mar; 13(1):6-11. PubMed ID: 38421388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.
    Hay PJ; Touyz S; Claudino AM; Lujic S; Smith CA; Madden S
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010827. PubMed ID: 30663033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.
    Koning E; Brietzke E
    Trends Psychiatry Psychother; 2024; 46():e20220597. PubMed ID: 37126863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.
    Adams DR; Allen H; Nicol GE; Cabassa LJ
    Transl Behav Med; 2024 Nov; 14(12):744-752. PubMed ID: 39419768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations for psychedelic-assisted therapy in military clinical settings.
    Hoener S; Wolfgang A; Nissan D; Howe E
    J Med Ethics; 2024 Mar; 50(4):258-262. PubMed ID: 37253556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.
    Rosa WE; Sager Z; Miller M; Bernstein I; Doerner Rinaldi A; Addicott K; Ljuslin M; Adrian C; Back AL; Beachy J; Bossis AP; Breitbart WS; Cosimano MP; Fischer SM; Guss J; Knighton E; Phelps J; Richards BD; Richards WA; Tulsky JA; Williams MT; Beaussant Y
    J Palliat Med; 2022 Aug; 25(8):1273-1281. PubMed ID: 35285721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.